A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acticor Biotech SA
Cash & Cash Equivalents Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Cash & Cash Equivalents
€3.9m
CAGR 3-Years
106%
CAGR 5-Years
34%
CAGR 10-Years
11%
Valneva SE
PAR:VLA
Cash & Cash Equivalents
€131.4m
CAGR 3-Years
-26%
CAGR 5-Years
24%
CAGR 10-Years
15%
Nanobiotix SA
PAR:NANO
Cash & Cash Equivalents
€75.3m
CAGR 3-Years
-10%
CAGR 5-Years
19%
CAGR 10-Years
11%
G
Genfit SA
PAR:GNFT
Cash & Cash Equivalents
€61.6m
CAGR 3-Years
-16%
CAGR 5-Years
-26%
CAGR 10-Years
-1%
Eurobio Scientific SA
PAR:ALERS
Cash & Cash Equivalents
€89m
CAGR 3-Years
7%
CAGR 5-Years
62%
CAGR 10-Years
20%
OSE Immunotherapeutics SA
PAR:OSE
Cash & Cash Equivalents
€25.9m
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.9m EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Cash & Cash Equivalents amounts to 3.9m EUR.

What is Acticor Biotech SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
11%

Over the last year, the Cash & Cash Equivalents growth was -41%. The average annual Cash & Cash Equivalents growth rates for Acticor Biotech SA have been 106% over the past three years , 34% over the past five years , and 11% over the past ten years .

Back to Top